COMP <GO>
MIND vs TMO // REVENUE GROWTH (YOY)
MIND Technology Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MIND 3
— TMO 9
▲ REVENUE GROWTH (YOY) LEADER: TMO
LAST: $4.19 (-1.41%) • MKT CAP: $38.1M
revenue-growth
-12.60%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
revenue-growth
3.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MIND VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MIND | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.60% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.10% | 9.30% | +0.80 | MIND | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.6x | 30.4x | -24.80 | MIND | /valuation <GO> |
| Free Cash Flow Yield | 5.05% | 2.40% | +2.65 | MIND | /fcf-yield <GO> |
| Operating Margin | 7.00% | 17.40% | -10.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 1.80% | 15.10% | -13.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -12.60% | 3.90% | -16.50 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.79 | 4.50 | -2.71 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.3 | 62.9 | -20.63 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 47.2x | 36.3x | +10.90 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $38.1M | $262.22B | -$262.18B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MIND REV | TMO REV | MIND GROSS % | TMO GROSS % | MIND FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $40.9M | $44.56B | 45.6% | — | $1.9M | $6.29B |
| FY 2024 | $46.9M | $42.88B | 44.7% | — | $214.0K | $7.27B |
| FY 2023 | $36.5M | $42.86B | — | — | -$5.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MIND // BETA —
TMO // BETA 0.94